Cerence has sued ElevenLabs in a Delaware federal court, alleging that the voice-AI company’s products infringe five of its patents. The complaint targets ElevenLabs’ AI agents, its creative platform and its programming interface, the core of the company’s fast-growing business.
Five Patents, Three Products
The five patents cover text-to-speech systems, suppression of acoustic interference, verification, and the generation and modification of synthetic voices. Cerence says it began notifying ElevenLabs of the alleged infringement in August, but the company continued making and selling the products.
ElevenLabs has not commented publicly on the suit in the material reviewed, and the complaint itself sits behind a paywall. What is public is the shape of the claim: five patents, three product lines, and months of warnings before Cerence went to court.
The complaint was filed in the United States District Court for the District of Delaware, the same court hearing other AI patent cases this month. No trial date has been set, and patent cases there typically take well over a year to reach a verdict.
Cerence’s Wider Patent Campaign
The suit is not Cerence’s first patent fight in AI voice technology. In May it filed its complaints against Amazon with the United States International Trade Commission and in federal court, seeking to block imports of smart devices it says infringe its voice patents. That investigation was instituted in June.
Cerence, spun out of Nuance Communications in 2019, has built its strategy around a portfolio of speech and conversational AI patents. It previously asserted nine patents against Samsung, another voice-AI defendant, and resolved that dispute through a cross-license and a $49.5 million payment, according to patent litigation records.
Our Read
A complaint is an allegation, not a finding, and five patents across three product lines is a broad claim. But Cerence is an operating company with a real portfolio and a record of settlements, not a shell. ElevenLabs’ agents, platform and API are what a patent holder would aim at.
The timing matters too. Voice AI is moving from demos into contact centres and enterprise workflows, where patent exposure turns into real money. ElevenLabs has been expanding rapidly into exactly those markets, with native integrations into the leading contact-centre platforms announced this month.
There is also a defensive read. A suit from an operating company with real products can push a fast-growing rival toward a licence rather than a courtroom fight. Cerence’s Samsung settlement shows that path works, and ElevenLabs may prefer paying for the technology to litigating over it.
Why It Matters
If Cerence’s patents hold up, voice-AI vendors building agents, creative tools and APIs face the same question about what its models are built on. The Amazon case shows Cerence is willing to pursue that question to an import ban. For ElevenLabs, the suit lands as its enterprise push gathers speed.
Background
ElevenLabs has faced patent claims before. Cedar Lane Technologies sued the company in September 2025 over a speech technology patent, and that case was voluntarily dismissed with prejudice in January 2026. A separate voice-cloning case brought by audiobook narrators and publishers was filed in Delaware in August 2024.
Source: Bloomberg Law


0 Comments